VIA
RMD icon

Virtus Investment Advisers’s ResMed RMD Stock Holding History

Virtus Investment Advisers’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,427
Closed -$1.67M – 502
2026
Q1 		$1.67M Sell
7,427
-8
-0.1% -$1.99K 0.46% 90
2025
Q4 		$1.79M Buy
7,435
+734
+11% +$188K 0.49% 84
2025
Q3 		$1.83M Buy
6,701
+825
+14% +$225K 0.53% 78
2025
Q2 		$1.52M Buy
5,876
+191
+3% +$45.6K 0.51% 67
2025
Q1 		$1.27M Buy
+5,685
New +$1.33M 0.35% 84
2023
Q1 		– Sell
-339
Closed -$70.6K – 334
2022
Q4 		$70.6K Hold
339
– – 0.05% 294
2022
Q3 		$74K Buy
+339
New +$77.2K 0.03% 321
2018
Q1 		– Sell
-2,740
Closed -$232K – 356
2017
Q4 		$232K Sell
2,740
-249
-8% -$20.6K 0.03% 384
2017
Q3 		$231K Buy
+2,989
New +$229K 0.02% 395

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtus Investment Advisers's RMD Position: Q2 2026 in Review

Virtus Investment Advisers sold out of ResMed (RMD) in Q2 2026, closing a stake of 7,427 shares — an estimated $1.67M sold.

Virtus Investment Advisers first reported a position in RMD in Q3 2017 and held it in 9 quarters. The position peaked at $1.83M in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Virtus Investment Advisers reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Virtus Investment Advisers sold 7,427 ResMed shares in Q2 2026, an estimated $1.67M.
  • Virtus Investment Advisers first reported a position in ResMed in Q3 2017 and held it in 9 quarters.
  • Virtus Investment Advisers's ResMed position peaked at $1.83M in Q3 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.